Dedicated to helping people with life-threatening conditions through scientific innovations and excellence
Inhibrx develops multivalent costimulatory agonists, checkpoint inhibitors, and therapeutics to invert the tumor microenvironment toward local immune activation.
|Difficulty finding data across multiple systems|
Without a formal tracking system, plasmid maps were distributed across multiple scientists’ computers. Finding the right plasmid map would involve walking through the lab to find the right scientist.
|Lack of data integrity|
Spreadsheets were used to track requests and information about plasmids, requiring extensive manual search and limiting user compliance.
|Tracking processes with paper|
Experimental notes were taken using a shared paper lab notebook, making it difficult to find experimental details and extract insights.
The Benchling Registry is a central source of truth for plasmids and enforces uniqueness constraints to ensure data integrity.
|Interlinked experimental details|
Scientists can link batches to relevant experiments, so their notes directly reflect all of the products and data they’ve generated.
|Streamlined IND filing|
Inhibrx uses Benchling Lab Notebook entries and unique Lab Notebook IDs to file for IND, saving months of time and effort.